Oligonucleotide Synthesis Market Size Worth $3.9 Billion by 2025: Grand View Research, Inc.
SAN FRANCISCO, December 13, 2018 /PRNewswire/ --
The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.
The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.
A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.
In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-?, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.
Growing usage of ready as well as custom oligos in genomic research is expected to drive the market
Column-based oligos have a higher per nucleotide base price compared to array-based oligos. As a result, column-based oligos accounted for the largest revenue share by product type in 2017
North America dominated the global market in 2017 as a result of large investments in genetic research and effective regulatory policies that encourage gene-based research activities in the region
Asian countries are expected to emerge as a key source of lucrative revenue generation during the forecast period. This is primarily due to growing awareness as well as popularity of genetic medicine among the population
The market is highly fragmented, with the presence of several major and emerging players offering DNAs, RNAs, and other oligos. Market competition is anticipated to increase with growing number of new entrants offering customized services
Some of the key companies in the market are BioAutomation; Integrated DNA Technologies, Inc.; LGC Biosearch Technologies; Agilent Technologies; GE Healthcare Dharmacon Inc.; and Gene Scripts.
White Biotechnology Market - The global white biotechnology market size was USD 203.28 billion in 2015 and is expected to witness growth at a CAGR of 10.2% over the forecast period.
Grand View Research has segmented the global oligonucleotide synthesis market on the basis of product, application, end use, and region:
Oligonucleotide Synthesis Product Outlook (Revenue, USD Million, 2014 - 2025)
Oligonucleotides
Oligonucleotides, By Product Type
Column-based Oligos
Array-based Oligos
Oligonucleotides, By Nucleic Acid Type
DNA
RNA
Equipment
Reagents
Services
Oligo Synthesis
25 nmol
50 nmol
200 nmol
1000 nmol
10,000 nmol
Purification
Modification
Oligonucleotide Synthesis Application Outlook (Revenue, USD Million, 2014 - 2025)
PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications
Oligonucleotide Synthesis End-use Outlook (Revenue, USD Million, 2014 - 2025)
Academic Research Institutes
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Oligonucleotide Synthesis Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
Explore the BI enabled intuitive market research database,Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Aurora Cannabis Inc. the Canadian based leading global medical cannabis company, is proud to announce the arrival of Aurora branded medical cannabis products to the New Zealand market. This new line of premium dried flowers represents a significant...
Viridian Therapeutics, Inc. , a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and financial results for the first quarter ending...
Enveric Biosciences, Inc , a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced that it has signed a non-binding...
Innoviva, Inc. ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic...
The "Global Market for Generative Biology 2024-2035" report has been added to ResearchAndMarkets.com's offering.
Revolutionizing Industries with Computational Biology
A comprehensive new report delves into the groundbreaking advancements in the...